| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2024 | BIO Bio-Rad Laboratories, Inc. | Ernst Timothy S69 | EVP, General Counsel &Sec | Sell | 2,500 | $330.55 | $826,375.00 | -42.4% | -13.4% | -19.6% | |
| Feb 28, 2024 | WST West Pharmaceutical Services Inc | Witherspoon Charles63 | VP &Treasurer | Sell | 2,019 | $358.62 | $724,061.45 | -50.5% | -8.4% | -37.7% | |
| Feb 28, 2024 | MEDP Medpace Holdings, Inc. | Keating Ashley M.67 | Director | Sell | 500 | $405.00 | $202,500.00 | -100% | -3.1% | -19.1% | |
| Feb 28, 2024 | IQV Iqvia Holdings Inc. | Knightly Kevin C57 | See Remarks | Sell | 8,607 | $250.17 | $2,153,175.56 | -40.4% | -9.4% | -25.5% | |
| Feb 28, 2024 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 20,000 | $567.45 | $11,348,954.99 | -1.1% | +0.1% | -8.5% | |
| Feb 28, 2024 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 100,000 | $403.01 | $40,300,500.00 | -1.0% | -3.1% | -19.1% | |
| Feb 28, 2024 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 100,000 | $403.01 | $40,300,500.00 | -1.0% | -3.1% | -19.1% | |
| Feb 27, 2024 | RVTY Revvity, Inc. | Vohra Tajinder S75 | Please See Remarks | Sell | 7,918 | $105.39 | $834,441.24 | -12.1% | +5.9% | +9.0% | |
| Feb 27, 2024 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 3,000 | $336.00 | $1,008,000.00 | -30.2% | -13.2% | -16.2% | |
| Feb 27, 2024 | WST West Pharmaceutical Services Inc | Green Eric Mark57 | President, CEO And Board Chair | Sell | 64,132 | $359.85 | $23,077,970.75 | -29.5% | -8.6% | -38.7% | |
| Feb 27, 2024 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 6,263 | $56.89 | $356,302.07 | -0.5% | -17.4% | -14.8% | |
| Feb 27, 2024 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 2,710 | $56.89 | $154,171.90 | -25.2% | -17.4% | -14.8% | |
| Feb 27, 2024 | EXAS Exact Sciences Corp | Baranick Brian75 | Gen. Mgr., Precision Oncology | Sell | 2,027 | $56.89 | $115,316.03 | -14.8% | -17.4% | -14.8% | |
| Feb 27, 2024 | EXAS Exact Sciences Corp | Orville Jacob A76 | General Manager, Screening | Sell | 1,879 | $56.89 | $106,896.31 | -13.8% | -17.4% | -14.8% | |
| Feb 27, 2024 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 1,880 | $56.89 | $106,953.20 | -2.5% | -17.4% | -14.8% | |
| Feb 27, 2024 | EXAS Exact Sciences Corp | Cunningham Everett54 | Chief Commercial Officer | Sell | 3,648 | $56.89 | $207,534.72 | -7.8% | -17.4% | -14.8% | |
| Feb 27, 2024 | EXAS Exact Sciences Corp | Herriott James75 | General Counsel | Sell | 784 | $56.89 | $44,601.76 | -8.8% | -17.4% | -14.8% | |
| Feb 26, 2024 | DHR Danaher Corp /de/ | Raskas Daniel67 | SVP - Corporate Development | Sell | 23,757 | $252.00 | $5,986,764.00 | -38.4% | +2.8% | -16.4% | |
| Feb 26, 2024 | MEDP Medpace Holdings, Inc. | Keating Ashley M.67 | Director | Sell | 500 | $404.29 | $202,146.64 | -66.3% | -3.1% | -15.5% | |
| Feb 26, 2024 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 156,928 | $401.07 | $62,938,688.64 | -1.5% | -3.1% | -15.5% | |
| Feb 26, 2024 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 156,928 | $401.07 | $62,938,688.64 | -1.5% | -3.1% | -15.5% | |
| Feb 23, 2024 | MTD Mettler Toledo International Inc/ | Vadala Shawn68 | Chief Financial Officer | Sell | 300 | $1,210.83 | $363,249.00 | -5.8% | +22.3% | +6.3% | |
| Feb 23, 2024 | WST West Pharmaceutical Services Inc | Abraham Silji62 | SVP, Chief Technology Officer | Sell | 7,012 | $365.00 | $2,559,380.00 | -60.1% | -10.6% | -42.6% | |
| Feb 23, 2024 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 1,021 | $59.72 | $60,974.12 | -1.4% | -6.0% | -14.4% | |
| Feb 23, 2024 | RVTY Revvity, Inc. | Goldberg Joel S58 | Please See Remarks | Sell | 835 | $105.13 | $87,783.55 | -2.0% | +7.1% | +9.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.